Immix Biopharma $100 million stock and pre-funded warrants offering
We advised the sole bookrunner and representative of the several underwriters on the offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Emera C$600 million at-the-market offering
We advised Emera on the offering
IREN $1.6 billion ordinary shares and $2.3 billion convertible notes offerings
We advised IREN on the concurrent offerings
Mirum Pharmaceuticals $200 million private placement
We advised the placement agents on the transaction
Immatics $125 million follow-on offering
We advised Immatics on the offering
Restaurant Brands International secondary offering and forward sale
We acted as counsel to the underwriter, forward seller and forward purchaser
GFL Environmental $750 million secondary offering
We advised the underwriters on the offering
Eos Energy $458 million stock and $600 million convertible notes offerings
We advised Eos Energy Enterprises on the concurrent offerings
Olema Pharmaceuticals $218.5 million follow-on offering
We advised the underwriters on the offering
Inventiva $172.5 million follow-on offering
We advised the underwriters on the offering